A three-in-one pill packed with anti-hypertensive drug, a statin and aspirin could fight heart diseases, according to a study published in Cochrane Database of Systematic Reviews. The polypill might reduce the death risk in heart attack and stroke patients.
By the end of next year, the polypill could be included into the World Health Organization’s list of essential medications, according to Dr. Mark Huffman, assistant professor, cardiology, medicine and preventive medicine, Illinois.
WHO has already announced that polypill could be one of five best-buy, low cost medication to prevent premature deaths and chronic diseases, worldwide. However, additional studies should be conducted, the health agency explained.
The polypill improved the treatment adherence by 33%. The polypills could be formulated with different drug doses, Dr. Mark concluded.
